OMCL Insider Trading

Insider Ownership Percentage: 2.64%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $567,600.00

Omnicell Insider Trading History Chart

This chart shows the insider buying and selling history at Omnicell by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$4M-$2M$0$2M$4MTotal Insider BuyingTotal Insider Selling

Omnicell Share Price & Price History

Current Price: $33.00
Price Change: Price Increase of +0.72 (2.23%)
As of 03/14/2025 05:00 PM ET

This chart shows the closing price history over time for OMCL up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
AprMayJunJulAugSepOctNovDecJanFebMar$33.00Closing price on 03/14/25:

SEC Filings (Institutional Ownership Changes) for Omnicell (NASDAQ:OMCL)

97.70% of Omnicell stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at OMCL by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$175Mbought$80MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$2B-$1B$0$1B$2BTotal InflowsTotal Outflows
Omnicell logo
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
Read More on Omnicell

Today's Range

Now: $33.00
Low: $32.40
High: $33.47

50 Day Range

MA: $40.71
Low: $32.28
High: $45.31

52 Week Range

Now: $33.00
Low: $25.12
High: $55.75

Volume

828,624 shs

Average Volume

496,113 shs

Market Capitalization

$1.54 billion

P/E Ratio

122.23

Dividend Yield

N/A

Beta

0.85

Who are the company insiders with the largest holdings of Omnicell?

Omnicell's top insider investors include:
  1. Randall A Lipps (CEO)
  2. Mark W Parrish (Director)
  3. Christine Marie Mellon (EVP)
Learn More about top insider investors at Omnicell.

Who are the major institutional investors of Omnicell?

Omnicell's top institutional investors include:
  1. Vanguard Group Inc. — 12.01%
  2. Dimensional Fund Advisors LP — 3.55%
  3. Lazard Asset Management LLC — 3.54%
  4. Victory Capital Management Inc. — 3.30%
  5. Champlain Investment Partners LLC — 3.18%
  6. Sumitomo Mitsui Trust Group Inc. — 3.13%
Learn More about top institutional investors of Omnicell stock.

Which institutional investors are selling Omnicell stock?

In the last quarter, OMCL stock was sold by these institutional investors:
  1. Bank of Montreal Can
  2. Assenagon Asset Management S.A.
  3. Marshall Wace LLP
  4. Bank of New York Mellon Corp
  5. Rockefeller Capital Management L.P.
  6. Bank of America Corp DE
  7. Bellevue Group AG
  8. Wellington Management Group LLP

Which institutional investors are buying Omnicell stock?

Within the last quarter, OMCL stock was acquired by institutional investors including:
  1. Lazard Asset Management LLC
  2. Sumitomo Mitsui Trust Group Inc.
  3. Toronto Dominion Bank
  4. Dimensional Fund Advisors LP
  5. Victory Capital Management Inc.
  6. Oberweis Asset Management Inc.
  7. Renaissance Technologies LLC
  8. Cubist Systematic Strategies LLC